DERMATA THERAPEUTICS INC (DRMA)
US2498454055 - Common Stock
Dermata Receives Approval from FDA for the Proprietary Name Xyngari(TM)
Unusual volume stocks are being observed in Monday's session.
On Monday, there are stocks with unusual volume. Let's take a look.
Friday's after hours session: top gainers and losers
After hours stock analysis on 2024-12-06: top gainers and losers in today's session.
Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
Life Sciences Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Life Sciences Investor Forum Agenda Announced for November 14th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Dermata Therapeutics to Present at the Life Sciences Investor Forum on Thursday, November 14, 2024
– Dermata Therapeutics invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com –
7 F-Rated Growth Stocks to Avoid Like the Plague in August 2024
If your growth stocks have stopped growing then you may be holding on to F-rated growth stocks. It's time to sell.
DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q2 2024
DRMA stock results show that Dermata Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Dermata Therapeutics (NASDAQ:DRMA) just reported results for the second quarter...
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them!
Why Is Azitra (AZTR) Stock Down 75% Today?
Azitra stock is falling on Wednesday as shares of AZTR come off of a massive rally yesterday alongside a new patent update.
Why Is Nuzee (NUZE) Stock Up 133% Today?
Nuzee stock is up on Wednesday with heavy trading of NUZE shares despite a lack of news from the coffee machine company.
Why Is Dermata Therapeutics (DRMA) Stock Up 200% Today?
Dermata Therapeutics stock is up on Wednesday with heavy trading of the company's shares despite a lack of news this morning.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!
DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q1 2024
DRMA stock results show that Dermata Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
DRMA Stock Earnings: Dermata Therapeutics Misses EPS for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Dermata Therapeutics (NASDAQ:DRMA) just reported results for the first quarter ...
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!